(JTA) — Friday is not just “Barbie” release day — moviegoers are also planning to fill theaters across the United States to see Christopher Nolan’s “Oppenheimer” biopic. Many hope it ...
In February, in the wake of an international AI Summit in Paris, Anthropic CEO Dario Amodei restated his belief that by 2030 ...
2d
Fintel on MSNOppenheimer Upgrades Nektar Therapeutics (NKTR)Fintel reports that on March 14, 2025, Oppenheimer upgraded their outlook for Nektar Therapeutics (NasdaqCM:NKTR) from ...
Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) was upgraded by equities research analysts at Oppenheimer from a “market ...
Netflix’s CCO Bela Bajaria believes Oppenheimer would have thrived on streaming. But would it really match its box office ...
Oppenheimer will be released on Netflix on March 21, 2025. The movie will be made available to stream on OTT platform with a ...
Ferguson (NASDAQ:FERG – Free Report) had its price target reduced by Oppenheimer from $234.00 to $189.00 in a report published on Wednesday morning,Benzinga reports. Oppenheimer currently has an ...
Christopher Nolan's Oppenheimer returned to theaters and is set to overtake Zack Snyder's Batman v. Superman as it climbs toward $1 billion.
Goldman Sachs analysts are cautioning that “confidence in the US growth story is moderating” and the U.S. stock market may continue to lag behind other global markets.
Oppenheimer lowered the firm’s price target on WhiteHorse Finance (WHF) to $11 from $12 on NAV decline, while keeping a Perform rating on the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results